Edition:
United Kingdom

Sorrento Therapeutics Inc (SRNE.OQ)

SRNE.OQ on NASDAQ Stock Exchange Capital Market

4.55USD
19 Sep 2018
Change (% chg)

$0.20 (+4.60%)
Prev Close
$4.35
Open
$4.35
Day's High
$4.62
Day's Low
$4.32
Volume
254,065
Avg. Vol
450,351
52-wk High
$10.65
52-wk Low
$1.70

Select another date:

Fri, May 11 2018

BRIEF-Sorrento Therapeutics Files For Resale Of Up To 1.38 Mln Shares Of Common Stock By The Selling Stockholders

* SORRENTO THERAPEUTICS INC FILES FOR RESALE OF UP TO 1.38 MILLION SHARES OF COMMON STOCK BY THE SELLING STOCKHOLDERS - SEC FILING Source text: (https://bit.ly/2IdNCY0) Further company coverage:

BRIEF-Sorrento Therapeutics Files For Resale Of Up To 34.16 Mln Shares Of Common Stock By Selling Stockholders

* SORRENTO THERAPEUTICS INC FILES FOR RESALE OF UP TO 34.16 MILLION SHARES OF COMMON STOCK BY THE SELLING STOCKHOLDERS - SEC FILING Source text: [https://bit.ly/2rzywFX] Further company coverage:

BRIEF-Sorrento Therapeutics Announces Unsecured $120.5M Convertible Note Financing

* SORRENTO THERAPEUTICS ANNOUNCES UNSECURED $120.5M CONVERTIBLE NOTE FINANCING

BRIEF-Sorrento Therapeutics Files ‍Prospectus Related To Offering

* SORRENTO THERAPEUTICS INC FILES ‍PROSPECTUS RELATED TO OFFERING OF UP TO 1.4 MILLION SHARES CO'S COMMON STOCK BY SELLING STOCKHOLDERS - SEC FILING Source text: (https://bit.ly/2IFWs1n) Further company coverage:

BRIEF-Sorrento Therapeutics Files ‍Prospectus Related To Offering

* SORRENTO THERAPEUTICS INC FILES ‍PROSPECTUS RELATED TO OFFERING OF UP TO 34.2 MILLION SHARES OF CO'S COMMON STOCK BY SELLING STOCKHOLDERS - SEC FILING Source text: (https://bit.ly/2pwUPvb) Further company coverage:

Select another date: